Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA clears Arcus' INDs for AB-928 and AB-122

June 12, 2018

Arcus Biosciences presents CD73 inhibitors

June 12, 2018

Merck & Co. patents DGAT2 inhibitors

June 12, 2018

NeuroRx completes phase IIb/III feasibility enrollment for NRX-101 in suicidal bipolar depression

June 12, 2018

First-in-human data on FDL-176 in healthy subjects presented

June 12, 2018

EMA grants PRIME designation for Themis' Chikungunya vaccine

June 12, 2018

Merck KGaA reports promising phase II data for tepotinib in advanced HCC

June 12, 2018

Lilly and AstraZeneca discontinue phase III trials of lanabecestat for Alzheimer's disease

June 12, 2018

Phase III data support ibrutinib/rituximab combination in Waldenstrom's macroglobulinemia

June 12, 2018

Boehringer Ingelheim initiates phase I study of BI-907828 in solid tumors

June 12, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...